|
|
|
|
|
|
Sponsored by: |
National Cancer Institute (NCI) |
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00671840 |
RATIONALE: Electromagnetic device tracking may help in planning diagnostic procedures and cancer treatment.
PURPOSE: This clinical trial is studying electromagnetic device tracking to see how well it works in patients undergoing CT-guided biopsy or ablation.
Condition | Intervention |
Unspecified Adult Solid Tumor, Protocol Specific |
Procedure: ablation Procedure: biopsy Procedure: computed tomography Procedure: electromagnetic tracking device procedure |
MedlinePlus related topics: | Cancer |
Study Type: | Interventional |
Study Design: | Diagnostic |
Official Title: | Electromagnetic Tracking of Devices During Interventional Procedures: A Pilot Study |
Estimated Enrollment: | 20 |
Study Start Date: | January 2005 |
Estimated Primary Completion Date: | January 2006 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Three to 6 multimodality adhesive fiducial markers (about 1 cm in diameter) are placed on the skin near the region of interest. Patients then undergo planning contrast-enhanced CT scan. The images are transferred to a computer and matched to the patient's body location by clicking on the fiducial marker on the image while simultaneously placing the electromagnetic tracking device on the actual selected fiducial marker on the patient's body. Patients then undergo CT-guided biopsy or ablation using a needle that contains the electromagnetic tracking device. Spatial data, registration errors, and navigation errors of the electromagnetic tracking device are recorded.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, Maryland | |||||
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office | Recruiting | ||||
Bethesda, Maryland, United States, 20892-1182 | |||||
Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center 888-NCI-1937 |
Principal Investigator: | Bradford Wood, MD | National Cancer Institute (NCI) |
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
Study ID Numbers: | CDR0000594244, NCI-05-CC-0091 |
First Received: | May 2, 2008 |
Last Updated: | October 8, 2008 |
ClinicalTrials.gov Identifier: | NCT00671840 |
Health Authority: | Unspecified |
|